AveXis Alternatives & Competitors
12 companies similar to AveXis — Specializing in groundbreaking gene therapies for rare neurological genetic dise...
Companies similar to AveXis
Apic Bio
Pioneering gene therapies for rare neurological and liver diseases, targeting Alpha-1 Anti...
Homology Medicines
Dedicated to addressing the root cause of rare genetic diseases and promising hope for pat...
VectivBio
Biotech company develops treatments for severe rare diseases, aims to become global leader...
Orchard Therapeutics - U.S.
Dedicated to transforming the lives of patients with severe and other genetic diseases thr...
Rival Readout
Competing with AveXis? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Alcyone Lifesciences
Empowering Precision Therapies for Rare Neurological Disorders
American Gene Technologies® International Inc.
Our mission is to leverage the power of gene and cell therapy to reduce human suffering fr...
Excision BioTherapeutics
Developing CRISPR-based therapies intended to cure viral infectious diseases.
Benitec Biopharma Inc.
Silencing genes for life
Nephrogen
Curative gene therapies for kidney diseases
Locanabio, Inc.
Creating RNA-targeting gene therapies to treat devastating diseases
Chinook Therapeutics, a Novartis Company
Changing the Course of Kidney Care
Harmony Biosciences
A fresh approach to helping patients thrive.
About AveXis
AveXis is a biotechnology startup specializing in groundbreaking gene therapies for rare neurological genetic diseases, impacting lives profoundly. Founded in 2013, the company was later acquired by Novartis on May 14, 2018, and adopted the name Novartis Gene Therapies in 2020. AveXis focuses on developing and bringing...
Gene Therapy, Neurological Genetic Diseases, Rare Diseases, Medical Innovation, Novartis, Acquisition, Life-Threatening Conditions, Research & Development, Therapeutic Innovations
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around AveXis: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at AveXis on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 30 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.